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Abstract
Background. In order to fulfil the complex needs of terminally ill patients, palliative care demands an in-
ter-professional collaborative network, including doctors, nurses, dieticians and social workers. Pharmacists 
in particular are essential members of this team, given the level of reliance on medications in this setting. 
The purpose of this review is to identify roles and services performed by palliative care pharmacists in 
dedicated palliative care settings worldwide and to map these findings against the Advanced Pharmacy 
Practice Framework. 
Material and methods. Quasi-systematic review. Search strategy: Google Scholar, Medline/PubMed, Scopus 
and Embase were searched utilizing selected MeSH terms.
Results. A total of 24 sources of information were included in the review. This literature was collected from 
a range of countries, predominantly from the USA, UK and Australia with singular reports from Mexico, 
Japan, Qatar, Canada, Poland and Sweden. The literature identifies that pharmacist roles in palliative care are 
varied and quite extensive. Roles that were specifically tailored to the palliative setting included: aggressive 
symptom management (in particular pain control), deprescribing, advising on the use of complementary 
and alternative therapies, extemporaneous compounding of non-standard dosage forms and maintaining 
a timely supply of medications. Pharmacists in the UK, USA, Canada and Australia were found to perform 
an advanced level of practice (as their reported roles fulfilled the criteria of the majority of the domains 
in the APPF). However, pharmacists in other countries, in particular Mexico and Poland, did not present 
such an extensive scope of practice.
Conclusion. The literature identifies that there are differences in the types of palliative pharmacist practice 
between countries, which may have varying levels of impact upon patient outcomes. As pharmacists can 
make significant contributions to palliative care, it is important to encourage the benchmarking of practice 
across different clinical settings and countries to promote a consistent and equitable practice. 
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Introduction
Palliative care is a multi-dimensional practice, 
comprising medical, physical and spiritual interven-
tions aimed at improving a patient’s quality of life 
[1]. In order to fulfil the complex needs of terminally 
ill patients, palliative care demands an inter-profes-
sional collaborative network, made up of doctors, 
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literature consisted of grey literature, review articles 
and reports as well as published studies. Due to the 
nature of the literature collected, a robust systematic 
review could not be performed. The amount and 
type of literature collected influenced the format of 
the review, precluding the full application of PRISMA 
guidelines, and leading to the adoption of a quasi-sys-
tematic review. 
The literature was retrieved by searching the fol-
lowing electronic databases: Embase, Scopus, Pub-
Med and Google Scholar. All sources of information 
including relevant studies, review papers and other 
publications were canvassed. It is acknowledged that 
particularly where practice is well established, it is not 
necessarily based on well-designed clinical trials. The-
refore, a broader perspective was obtained by perfor-
ming a supplemental Google search using the same 
search terms to identify relevant grey literature.
Search strategy
A two-tiered search strategy was used (Fig. 1). In 
Tier 1, a search was performed utilising the following 
Medical Subject Headings (MeSH) headings/keywords: 
pharmacist interventions, clinical pharmacist, pal-
liative care/therapy, hospice, clinical practice, and 
pharmacist role/activities. The Boolean operator ‘AND’ 
was employed to combine the search terms. Manual 
bibliographic searches of all relevant articles were also 
performed in order to identify any articles that were 
not identified in the electronic searches. In Tier 2 of the 
search, relevant grey literature was identified through 
a Google search using the same MeSH terms. This tier 
was dedicated to finding service standards, position 
descriptions as well as descriptive reports.
Study selection
The selection criteria for the searches restricted 
the content to the following: (i) review articles (inclu-
ding literature reviews and opinion pieces), research 
articles, or grey literature (ii) with results containing 
information on pharmacist led activities relating to 
terminal patients in the palliative care setting and (iii) 
written in the English language. All full text articles 
meeting this criteria were retrieved and all evaluations 
pertaining to the types of pharmacist roles in palliative 
care were included in the review. Since palliative care 
has evolved in many countries in recent years we ap-
plied a date limit so that only recent articles published 
from the year 2000 or later, that is, 2000–2017, were 
taken into account.
The advanced pharmacy practice framework
The palliative care roles identified in the review were 
mapped out against the proposed Advanced Pharmacy 
nurses, dieticians, social workers and pharmacists 
[2, 3]. The latter, in particular, are essential members 
of this team, especially when considering the level 
of reliance on medications in this setting. Termi-
nal patients experience increased symptom burden 
requiring more intensified and potentially unique 
pharmacological dosing or regimens [4]. Pain in par-
ticular is a distressing symptom that requires specia-
lised analgesia (e.g. special medication formulations, 
routes of administration) as bodily functions begin 
to deteriorate when the disease progresses [4] Many 
patients also have complex medication regimens 
comprising off-label or unlicensed prescribing of 
medicines, which increases their risk of medication 
related problems [5, 6].
It is reported that upon referral to a dedicated 
palliative care setting, 20% of patients are taking at 
least 8 medications [2, 7]. A study by Currow et.al. 
found that the number of medications prescribed to 
a palliative patient increased as death approached 
[7]. As such, pharmacists hold an integral position in 
medication management as well as palliative patient 
care. The literature highlights the positive impact of 
pharmacist practice through improved symptom con-
trol, identifying, preventing and resolving medication 
related problems, providing medication counselling 
as well as patient psychological support [6, 8–10]. 
However, palliative care is provided through a va-
riety of settings, including patient’s own homes, ho-
spices and palliative care wards in hospitals. As such 
the roles performed by pharmacists in these settings 
may have a wide scope of practice. Little research has 
been undertaken to provide a comprehensive overview 
of pharmacist services in palliative care on a global 
scale. It is important to understand differences in 
practice between palliative care settings, to determi-
ne whether there are any inequalities in medication 
management. Therefore, the purpose of this review 
is to identify the roles performed by palliative care 
pharmacists in palliative care settings (inpatient and 
outpatient) worldwide and to map these services 
against the Advanced Pharmacy Practice Framework 
(APPF). 
Material and methods 
We performed a quasi-systematic review (a review 
that possesses some elements of a systematic review, 
including pre-defined selection criteria, however, inc-
ludes grey literature and does not present a critical 
evaluation of the quality of studies) and extracted 
relevant publications relating to roles, interventions, 
activities and functions performed by pharmacists 
in palliative care settings [11–13]. The majority of 
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Practice Framework (APPF). The APPF describes the 
specific competencies, level of knowledge and skills 
required of a pharmacist to perform at an advanced le-
vel [14]. It is directed at pharmacy practice in any patient 
group, with the overarching aim of providing patient 
centered care and optimizing the use of medicines. De-
veloped by the APPF Steering Committee and published 
by the Pharmacy Board of Australia, the framework 
proposes 5 domains that demonstrate an advanced 
level of pharmaceutical care services (Fig. 2).
Results
A total of 24 sources of information were included 
in the review (Tab. 1). This literature was collected from 
a range of countries, predominantly from the USA 
(12 of 24), Australia (4 of 24) and the UK (3 of 24) 
with singular reports from the Mexico, Japan, Qatar, 
Canada, Poland and Sweden. The types of articles 
collected consisted of qualitative (1) and quantitative 
studies (8) (total 9 of 24), review articles (2 of 24) and 
reports (2 of 24) as well as grey literature including 
feature articles (5 of 24), commentaries (2 of 24), 
conference abstracts (2 of 24), guidelines (1 of 24) 
and a book chapter (1 of 24). 
Overall, the pharmacist roles identified in the litera-
ture were widespread across the pharmaceutical service 
spectrum and acknowledged pharmacist involvement 
in palliative care wards (h) (18 out of 24), hospices 
(hp) (3 out of 24) and in home-based care settings (hb) 
(3 out of 24) (Table 2). The literature from Australia, 
USA and the UK has reported that pharmacists provi-
ded pharmaceutical care services to both home care 
settings, (through community pharmacy), as well as 
in palliative care wards [3, 15–26]. A 2015 report by 
Gibbs identified that approximately 200 pharmacists 
were members of palliative care teams in the UK [17]. 
Gilbar et.al. found that 86% and 55% of palliative wards 
surveyed in Canada and Australia respectively identified 
pharmacist involvement in the palliative care team [18]. 
In the USA, Dispennette et.al. reported that pharmacists 
provided palliative pharmaceutical care services in diffe-
rent locations across the continuum of care, with 63% 
of their time spent in the acute care setting, 30% in the 
ambulatory care setting, and 7% in other settings (not 
specified) [26]. The literature collected from Japan (h), 
Qatar (h), Poland (hp) and Mexico (c) reported that 
pharmaceutical care services in these countries were 
provided in one setting, either hospitals (h), hospices 
(hp) or community care centres (c). 
Number of total articles found:
pharmacist rules, palliative care
N = 147
Primary relevant publications
identied based on titles:
N = 110
Subsequent review of titles 
and abstracts for relevance: N = 61
excluded for irrelevance 
to objectives of review
Review of full-text papers,
N = 36 excluded based on:
— unrelated to objectives of review: N = 10,
— dierent setting to palliative care: N = 16,
— did not describe pharmacist’s role: N = 10.
Additional Google search of MeSH terms 
to identify grey literature: N = 11
— commentaries: N = 2,
— conference abstracts: N = 2,
— feature articles: N = 5,
— guidelines: N = 1,
— book chapter: N = 1.
Full-text articles that responded
to eligibility criteria:
N = 49
References included 
in the nal review:
N = 24
Figure 1. Search strategy
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Figure 2. Pharmacist practice in the palliative care setting mapped against the advanced pharmacy practice framework. 
Adapted from: “An Advanced Pharmacy Practice Framework for Australia”, http://advancedpharmacypractice.com.au/ 
/download/framework/advanced-pharmacy-practice-framework.pdf [14]
Table 1. References used in the review
Author Year Country Type of 
Study
Setting Main Findings
Atayee R. 
et.al.
[8]
2008 USA Prospective 
study 
Ambulatory 
palliative 
care
The palliative care pharmacist performed daily team 
rounds, direct patient care, attended various lectu-
res, independently assessed patients for symptom 
management, resolve and prevent medication-rela-
ted problems, initiate/modify treatment regimens. 
Austwick E., 
Brooks D.
[15]
2004 UK Review Palliative 
care
The pharmacist performs several services in the 
palliative clinic including: medication histories, 
provision of clinical support for staff, counselling 
of patients and identification of medication-related 
problems.
Barbee Jr J. 
et.al.
[16]
2016 USA Electronic 
article
Palliative 
care
Pharmacists are essential in developing an indivi-
dualized treatment regimen for each patient. They 
perform interventions including include medication 
reconciliation, patient education, geriatrics con-
sultation, and multidisciplinary team consults to 
improve medication management. 
Demler T.L. 
[32]
2016 USA Electronic 
article
Palliative 
care
Pharmacists, particularly those with special training 
or experience in palliative care, bring added value 
to the services provided by hospice by counselling 
the patient in care, updating and educating the 
team regarding medications, and working with 
the team — particularly nursing staff — to closely 
monitor therapeutic responses.
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Table 1 (cont). References used in the review
Dispennette 
R., Hall L.
[26]
2015 USA Prospective 
survey
Palliative 
care
The majority of pharmacists provided a variety of 
services, including medication regimen reviews, 
education of staff, dosage adjustments, opioid 
dose conversions, actively involved in precepting 
pharmacy learners and teaching in didactic settin-
gs. 
Escutia 
Gutierrez R. 
et.al.
[34]
2007 Mexico Report Palliative 
care insti-
tute
The palliative care institute performs three major 
services including a medication distribution system, 
medication information service, pharmacovigilance 
program and a home pharmacotherapy follow-up 
pilot program. 
Gibbs M. 
[17]
2015 UK Book chapter Palliative 
care
Pharmacists are essential members of the palliative 
care team in the UK. They perform a wide range of 
roles including: timely provision of medications, co-
unselling patients, educating other staff members, 
providing advice and guidance on the safe use of 
medications and medication order review. 
Gilbar P.,
Stefaniuk K.
[18]
2002 Australia
Canada
Prospective 
survey
Palliative 
care wards
Australian pharmacists were more involved in 
administrative duties and basic supply functions, 
whereas Canadian pharmacists had greater partici-
pation in team meetings and ward rounds. Medi-
cation review was the most commonly performed 
role. 
Herndon C. 
et.al.
[19]
2016 USA ASHP Guide-
lines
Palliative 
and Hospi-
ce Care
Highlights what roles pharmacists need to perform 
in US palliative care settings, including: direct 
patient care, medication order review and reconci-
liation, education and medication counselling and 
administrative roles.
Hill R. et.al.
[28] 
2007 USA Feature 
article
Palliative 
care
Pharmacist responsibilities involve answering 
questions related to prescriptions, communication 
with other health care staff, providing educational 
in-service programs to staff, reviewing medication 
regimens, monitoring patient symptoms, managing 
patients alternative therapies and extemporaneo-
usly compounding medications. 
Hussainy S. 
et.al.
[20]
2011 Australia Prospective 
study
Community 
palliative 
care
The project pharmacist demonstrated seven major 
roles: medication review, education for patients/
carers, ensuring ongoing access to medications, 
providing information/education to team members, 
consulting/collaborating with team members, lia-
ising with other health care professionals, symptom 
management. 
Ise Y. et.al.
[29]
2014 Japan Prospective 
survey
Palliative 
care wards 
in cancer 
hospitals
Pharmacists perform a moderate level of clinical 
services for palliative care units. There is more 
emphasis on research and research roles including 
organising multidisciplinary conferences, and provi-
ding information to the team. 
Jiwa M.  
et.al.
[3]
2007 Australia Report Palliative 
care
Primary role for community pharmacists is the safe 
and efficient provision of medication and as a sour-
ce of advice to patients and their carers. Other roles 
include: pain management, medication manage-
ment reviews and psychosocial care. 
Khan J.  
et.al.
[27]
2016 UK Conference 
abstract
Paediatric 
palliative 
care 
Paediatric palliative pharmacists reported perfor-
ming the following roles: supplying medications, 
responding to medication related enquiries, provi-
ding advice to other health care staff on compatibi-
lity of medications. 
Leverence K.
[35]
2015 USA Commentary Palliative 
care
Involved in multidisciplinary meetings, patient care 
visits, medication review, consultations with nurses 
and doctors, maintain formulary, medication poli-
cies/procedures and quality assurance. 
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Domain 1: Professional and ethical practice
Two USA articles and one UK report identified that 
palliative care pharmacists have communicated with 
regulatory and licensing agencies to ensure practi-
ce compliance with local, state and federal policies 
relating to medication management (supply, prescri-
bing, storage and documentation of medicines use) 
[17, 19, 25]. Pharmacists in the USA were responsible 
for developing and updating medication use policies 
in accordance with evidence-based practices [19]. The 
ASHP guidelines also identified that it was an ‘essen-
tial’ role of the palliative pharmacist to ensure that 
practice procedures relating specifically to the use 
of analgesics and other symptom-based treatments 
Table 1 (cont). References used in the review
Mc Crate 
Protus B, 
et.al.
[21]
2012 USA Feature 
article
Hospice Administrative duties, including medication use 
evaluations, development of guidelines and poli-
cies, medication therapy management and clinical 
education are important roles for pharmacists to 
perform in the hospice arena.
Naidu D. 
et.al. [36]
2015 USA Conference 
abstract
Palliative 
ward
Within 24 hours of pharmacist intervention, an 
average pain score reduction (0 to 10 pain scale) 
of 2.6 points was seen in acute pain patients and 
2.8 points was seen in chronic pain patients. In 
patients who had a documented pain goal, the 
pharmacist was able to meet the goal in 91% of 
these patients.
Norrstrom B. 
et.al.
[30]
2010 Sweden Prospective 
study
Palliative 
home care 
center
The inclusion of pharmaceutical expertise on a 
palliative care team is valuable, improving rational 
medication-handling processes including medi-
cation cost savings, and for queries regarding 
pharmaceutical issues. 
Pawlowska I. 
et.al.
[31]
2016 Poland Cross-sec-
tional study 
(survey)
Residential 
hospices
Pharmacists in Polish hospices rarely perform clini-
cal services, and most are not considered members 
of the therapeutic team. Administrative roles are 
highly performed, including medication use docu-
mentation, managing the formulary etc.
Pruskowski J. 
et.al.
[22]
2017 USA Feature 
article
Palliative 
care
A palliative care clinical pharmacist can improve 
patient outcomes through the rational use of me-
dications — important roles include de-prescribing 
and improving pain control and symptom manage-
ment. 
Swetenham K. 
et.al.
[23]
2014 Australia Qualitative 
study
Palliative 
care
Several advanced pharmacy practice roles were 
identified, including: providing home medicines 
reviews for community palliative care patients, im-
prove access to medications on a around the clock 
basis, developing quality and safety framework, 
and identifying key performance indicators for 
evaluating the impact of this service. 
Walker K.
[24]
2010 USA Review Palliative 
care
Pharmacists are identified as pivotal members of 
the multi-disciplinary palliative team and perform 
roles including: medication histories, medication 
summaries, identification of medication-related 
problems, medication counselling and providing 
medication information. 
Walker K. 
et.al.
[25]
2010 USA Commentary Palliative 
Care
Several roles are performed by pharmacists which 
have been broken up into sections: provision of 
pharmaceuticals, optimising medication regimens, 
education and medication information, patient 
safety and administrative/formulary management.
Wilby K. 
et.al.
[3] 
2014 Qatar Prospective 
study
Palliative 
Care ward
Clinical pharmacy interventions were identified, 
which included: discontinuation and initiation of 
medication therapy, education, counselling and 
increasing medication doses.
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prescribed by other health care professionals in the 
palliative setting adhered to accreditation, legal, re-
gulatory and safety requirements [19]. 
Domain 2: Communication, collaboration 
and self-management
It was particularly emphasised within the lite-
rature that pharmacists played a significant role as 
a member of the palliative interdisciplinary team, 
performing both a direct patient care role as well as 
a supportive role [3, 17–20, 27]. In this capacity, they 
assisted other medical staff with medication-related 
enquiries, participated in team rounds, clinical meetin-
gs and consulted with the therapeutic team, advising 
on pharmacotherapy [8, 15, 18–21, 23–31]. Studies 
from the USA highlighted that information requests 
commonly related to the use of alternative routes of 
administration, non-standard dosage forms, dosage 
adjustments, complementary and alternative thera-
pies, tapering or discontinuing medicines, off-label use 
of medicines, opioid dose conversions, psychological 
issues, medication interactions and differentiating 
between allergies and pseudoallergies [16, 26, 32]. 
Gilbar found that pharmacists in Australia and Ca-
nada were considered to be important members of 
the palliative care team, however participation in 
interdisciplinary team rounds (72.9% vs. 40.0%) and 
team meetings (64.4% vs. 45.2%) was more likely in 
Canada than Australia [18]. Only one paediatric-ba-
sed study was included in the review, and Khan et. 
al. observed that in a  paediatric palliative care unit 
in the UK, pharmacists routinely provided advice to 
other members of the interdisciplinary team on the 
compatibility and stability of medications, and that 
these contributions were highly valued by the medical 
staff (rated 9 out of 10) [27]. Other literature reported 
that in addition to providing a medical information 
service to medical staff, palliative care pharmacists 
Table 2. Definitions
Term Definition
Palliative care “Specialized medical care for people living with serious illness. It focuses on providing 
relief from the symptoms and stress of a serious illness, whatever the diagnosis. The 
goal is to improve quality of life for both the patient and the family. Palliative care is 
provided by a team of doctors, nurses and other specialists who work together with 
a patient’s other doctors to provide an extra layer of support. It is appropriate at any 
age and at any stage in a serious illness, including for those who are seeking curative 
or life prolonging treatments.”
“Most palliative care consultation teams are interdisciplinary and consist of doctors (inc-
luding generalists and specialists, as well as psychiatrists), nurse practitioners, registered 
nurses, social workers, psychologists, chaplains, pharmacists, and volunteers” [45].
Community-based palliative 
care
“Community-based palliative care programs provide important continuity of care for 
patients who are discharged from the hospital after being seen by an inpatient pal-
liative care consultation service. In addition, community palliative care providers can 
act as consultants for patients who are not hospitalized but who have serious chronic 
illnesses, symptom distress, and difficulty managing complex treatment regimens. 
Community palliative care teams provide pain and symptom management, psychoso-
cial and family support, skilled communication about patient and family concerns and 
priorities and how to address them, and coordination of home care needs, including 
housing, food, transportation, and equipment. Patients receive palliative care in 
conjunction with life-prolonging disease treatments. These services can be provided 
within the home, within a nursing home, within a palliative care outpatient practice, 
clinics, over the phone or through embedding or integration of a palliative care team 
within an existing outpatient primary care or specialty practice”[45, 46].
Home-based palliative care “The provision of health services by formal and informal caregivers in the home in or-
der to promote, restore, and maintain a person’s maximum level of comfort, function, 
and health including care towards a dignified death.”[47]
Hospice-based palliative 
care
“Hospice is a model for delivery of palliative care for patients at the end of life when 
curative or life-prolonging therapy is no longer beneficial”[45].
Hospital-based palliative 
care
“Hospital palliative care programs improve physical, psychosocial, and spiritual 
suffering of patients and families who are hospitalized with serious illnesses. Models 
of hospital-based palliative care services include palliative care consult services and 
dedicated inpatient palliative care units”[45].
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also provided education and training to other staff 
members on medication use in palliative care, as 
well as updates on clinical guidelines [15, 17–19, 21, 
24–26, 28, 31, 33].
As well as supporting other medical staff, phar-
macists were reported to have a strong role in the 
counselling and support of patients and their family 
members and carers. Studies showed that pharmacists 
commonly provided in-depth information and advice 
about symptom management and their medications 
[3, 15, 18–20, 23–25, 29, 31, 33, 34]. In particular, pro-
viding information about the correct administration 
of medications (i.e. patches, puffers etc.), the use of 
complementary and alternative therapies, discussing 
patient fears about overdosing or addiction with 
opioid use, and the risks and side-effects of prescribed 
treatment regimens [16, 25]. One UK-based article 
highlighted that pharmacists provided patients with 
written information, as well as patient information 
leaflets [15]. Gibbs identified that it was important for 
pharmacists to encourage and support suitable pa-
tients to independently manage their medications as 
it promoted confidence and control and contributed 
to successful discharge from palliative units to home 
care settings, preventing future re-admissions due to 
medication management issues [17]. Furthermore, 
an Australian study emphasised the importance of the 
pharmacist in a community pharmacy, in providing 
psychological support to home-based and communi-
ty-based patients and family members [20]. 
Domain 3: Leadership and management
Management or administrative roles, comprising 
organising the formulary (purchasing, stock control 
and storage), quality assurance (i.e. medication use 
evaluations), developing department policies, han-
dling the medication budget, and attending non-clini-
cal meetings were commonly reported in the literature 
[3, 18–21, 23, 25, 27, 30, 31, 34, 35]. Pharmacists in 
Poland, Australia and the USA were highly involved 
in administrative duties, whereas no information was 
available on these roles from Japan, Mexico, Qatar and 
the UK. (Table 3). A comparative study in Australia and 
Canada highlighted that twice as many Australians 
(59.5%) as Canadians (28.8%) considered admini-
strative roles to be routine duties in the palliative care 
setting [18]. Similarly, Pawlowska et.al. identified that 
Polish pharmacists in hospices were highly involved 
in administrative work, in particular in managing the 
purchase, supply and distribution of medications thro-
ugh the hospice [31]. This was attributed to the strict 
legal regulations surrounding pharmacist practice in 
hospices, which require pharmacist involvement in 
procurement and documentation relating to medica-
tion supply [31]. McCrate Protus highlights that in the 
USA, administrative activities such as the processing 
Table 3. Roles performed by pharmacist in palliative care settings
Countries Roles Performed
Aaustralia Managing medication formulary [18]
Attending non-clinical meetings [18]
Quality assurance, identifying key performance indicators for evaluating the impact of pharmacy servi-
ces [18, 23]
Managing the medication budget [18]
Supply/access to medications for patients around the clock [3, 20, 23]
Developing symptom management/medication use protocols [3, 18, 20, 23]
Sourcing household aids [3]
Home medicine review [3, 20, 23]
Counselling/education for patients - source of advice for patients and carers, in-depth information and 
advice about symptom management, medications [3, 18, 20, 23]
Psychological/interpersonal support for patients and carers [3]
Monitoring patient symptoms and managing them accordingly [20]
Patient assessments [18]
Medication review [18, 20, 23]
Participation in interdisciplinary team rounds and clinical meetings [18]
Medication-related information service to team members — e.g. off-label medications, dosing [18, 20, 
23]
Consultation/liaison with other members of the therapeutic team relating to advising on medication 
therapy and updating medication chart [20, 23]
Education for staff [18]
Participation in research and conferences [18]
Extemporaneous compounding [18]
Dispensing [18]
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Table 3 (cont.). Roles performed by pharmacist in palliative care settings
Canada Managing medication formulary [18]
Attend non-clinical meetings [18]
Quality assurance [18]
Manage medication budget [18]
Medication supply to inpatient [18]
Medication use protocols [18]
Patient assessments [18]
Review of medication orders [18]
Participation in interdisciplinary team rounds and meetings [18]
Advice on medication therapy [18]
Medication information service [18]
Education to staff and patients [18]
Teaching, research, conferences [18]
Extemporaneous compounding [18]
Dispensing [18]
Japan Counselling [29]
Managing adverse effects and medication interactions [29]
Participation in ward rounds [29]
Providing medications information to staff [29]
Participation in conferences [29]
Mexico Provision and access to medications [34]
Counselling patients [34]
Home visits to patients [34]
Monitor adverse drug reactions (ADR’s) [34]
Medication information service [34]
Option to dispense medication at the patients doorstep [34]
Poland Participation in tenders related to purchasing medication [31]
Writing of guidelines for usage of medications at hospice [31]
Documenting medication and medical device donations [31]
Educating patients [31]
Therapeutic drug monitoring (TDM) [31]
Monitoring adverse drug reactions (ADRs) [31]
Rationalising of therapy [31]
Providing medication information to medical staff [31]
Training hospice staff/volunteers [31]
Participation in clinical trials in hospices [31]
Dispensing medications [31]
Qatar Counselling patients [33]
Patient and staff education [33]
Laboratory monitoring [33]
Making pharmacotherapy recommendations to medical staff related to discontinuing therapy, Initiating 
therapy, dose increases, route of administration, dose frequency etc. [33]
Referral of patients to other consult services [33]
Sweden Checking the expiry dates of medications in stock [30]
Meetings with the staff to develop and improve the medication-handling process [30]
Dispensing of medications into dosette boxes as well as for storage and other medication-handling 
procedures [30]
Give advice to medical staff regarding different pharmaceutical issues, such as extemporaneously com-
pounded medications [30]
Support medical staff in the use of licensed medicinal products and to follow up medications that could 
not be delivered from drug companies [30]
Inform medical staff about new medication strengths, new packages, withdrawals of medications from 
the market and newly approved medications. Address complaints about medications [30]
UK Prompt and efficient supply of medications to patients [15, 17, 27]
Medication chart review [15, 17]
Performing medication histories [15, 17]
Maintaining a patients medication summary sheet [15]
Identifying and resolving medication-related problems [15, 17]
Counselling/education for patients and providing them with written medication information [15, 17]
Participation in ward rounds [15]
Answering medication related enquiries [17, 27]
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of medication reimbursement claims and medication 
utilisation evaluations were mainstay activities of ho-
spice pharmacists [21]. Swedish pharmacists were also 
involved in checking expiry states of stock, and ma-
naging the storage conditions in the dispensary [30]. 
Domain 4: Promote and contribute  
to optimal use of medicines
Overall, patient-centred, clinical roles were the 
most highly reported throughout the literature. Each 
country identified in the review recognised pharmacist 
involvement in direct patient care duties (Tab. 3, Fig. 2). 
These roles encompassed a wide scope of practice, 
including medication review, patient assessments, mo-
nitoring adverse effects and medication interactions, 
medication reconciliation/history taking, laboratory 
monitoring, and prescribing [8, 15, 17–20, 23–26, 28, 
29, 33–35]  (Tab. 3). Pharmacists in the USA, UK, Au-
stralia and Canada reported the highest involvement in 
these roles, whereas Poland, Mexico, Sweden and Qa-
tar acknowledged that clinical roles were not well es-
tablished in their respective countries [30, 31, 33, 34]. 
The average time that pharmacists spent on direct 
patient care activities varied in reports: Atayee et al. 
highlighted that pharmacists in their USA-based study 
spent approximately 2.5 hours per patient per visit, 
which was dedicated to preparing for patient consul-
tations, assessing patient symptoms, communicating 
with clinicians, and making pharmacotherapy-related 
suggestions [8]. Gilbar identified that 35.7% and 61% 
Table 3 (cont.). Roles performed by pharmacist in palliative care settings
UK Providing advice/clinical support to nursing and medical staff on pharmacotherapy regimens, off-label 
prescribing, complementary medications [15, 17, 27]
Provision of education to nursing staff on medication use in palliative care [15, 17]
Extemporaneous compounding of non-standard dosage forms [17]
Performing economic reviews [17]
USA Formulary management [21, 25, 35]
Interdisciplinary meetings [35]
Quality assurance, medication utilisation evaluations [19, 21, 35]
Cost-containment measures [21]
Support medication contract negotiations with pharmacy vendors (i.e. wholesalers) [19)
Stock medications [25]
Development of medication policies and procedures, symptom management/clinical practice guidelines 
[19, 21, 24, 25, 35]
Claims processing [21]
Re-imbursement structure for pharmacist services [19]
Participation in drug therapeutics committees [19, 25]
Communication with regulatory and licensing agencies to ensure practice compliance with local, state 
and federal policies [24]
Aid with accreditation, legal, regulatory and safety requirements related to the use of analgesics and 
other symptom based treatments [19]
Multi-disciplinary and solo patient visits [35]
Counselling patients and family members [19, 24, 25]
Independently assess patients for pain and symptom management [8, 19, 22, 32]
Monitor adverse drug reactions, drug-drug reactions [28]
Monitor therapeutic response (i.e. warfarin), patient symptoms [25, 28]
Medication review [8, 25, 26, 28, 32, 35]
Medication history/reconciliation [16, 19, 24, 25]
Determine cost-effectiveness of medication regimen [25]
Investigate medication errors [25]
Identify, resolve and prevent medication related problems [8, 24, 36]
Participation in inter-disciplinary ward rounds [8]
Consultations with nurses and doctors [28, 35]
Medication information service, assistance with opioid conversion calculations [24–26, 28, 32]
Recommendations for symptom management, alternative routes of administration, discontinuing thera-
py, alternative therapies, appropriate medication therapy, advise on off-label medication use, complian-
ce aids, dosage adjustments, allergies, tapering medications [8, 16, 19, 21, 25, 26, 28, 32]
Educational in-services, continuing education programs for pharmacy and other medical staff, updating 
on new clinical guidelines [19, 21, 24-26, 28]
Precepting students, teaching in didactic settings [21, 26]
Participation in conferences and research [19, 21, 25]
Extemporaneous compounding of non-commercially available medications, formulations [19, 25, 28, 32]
Dispensing [25]
De-prescribing [16, 22]
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of pharmacists in Australia and Canada have respecti-
vely spent between 10–20 hours per week in palliative 
care [18]. Roles that were specifically performed in the 
palliative setting included aggressive pain control and 
symptom management, deprescribing, identification 
of adverse effects and interactions, extemporaneous 
compounding of non-standard dosage forms, use of 
complementary and alternative treatment regimens, 
use of off-label medications, and ongoing supply of 
appropriate medications [3, 8, 15, 17–20, 22–25, 
27–29, 31, 32, 34, 36]. Symptom management in 
particular was a highly emphasised role, with Atayee 
et.al. reporting that 93% of referrals made to the 
pharmacist in their study were for pain management 
[8]. In their study utilising a retrospective review of 
patient medical records, Naidu et.al. observed that 
within 24 hours of a pharmacist intervention, the 
average pain score in acute and chronic pain patients 
was reduced by 2.6 and 2.8 points (on a 10 point 
pain scale) respectively [36]. Furthermore, palliative 
care often involves the prescribing of off-label medi-
cation, and Gibbs indicated that it was important for 
pharmacists to be involved in the decision-making 
process to ensure these medications were being used 
appropriately and with accountability [17]. 
An effective supply function was identified as an im-
portant pharmacist responsibility, particularly in com-
munity-based settings [3, 15, 17, 20, 23, 25, 27, 30, 
34]. Often patients undergoing palliative care require 
medications as well as dose administration aids that 
are not commonly used and rely on pharmacists for 
a timely and ongoing supply [3]. Jiwa et.al. highlighted 
that this role was challenging due to the nature of 
the medications required (i.e. opioids, short shelf-life, 
large batches), however, was an important function as 
missing a dose of medication could potentially have 
significant effects on patients’ quality of life [3]. 
Interestingly, only studies from Australia identified 
the performance of home medicine reviews (HMR’s) 
for patients in home-based palliative care settings 
[3, 20, 23]. These reviews were identified as an extra 
level of support for patients who were being treated 
at home, and facilitated a better relationship between 
pharmacists and other primary care providers such as 
community care nurses [3, 23]. 
Other roles that were also commonly reported 
as key elements in optimizing medication manage-
ment in palliative patients, but have been discussed 
elsewhere in this review, included: participation in 
interdisciplinary ward rounds, counseling patients, 
providing medication information to other staff, and 
providing education and training to other pharmacists 
and other medical staff [3, 8, 15–21, 23–34]. 
Domain 5: Critical analysis, research  
and education
The ASHP guidelines state that research activities 
should be pursued by palliative care pharmacists 
when possible, and extend to in the preparation of 
publications, developing clinical guidelines, guidance 
documents or treatment algorithms as well as provi-
ding education to student pharmacists and members 
of the interdisciplinary team [19]. However, research 
and education roles were not commonly reported in 
the literature. Several articles indicated that pharma-
cists did perform research activities such as: partici-
pation in conferences, contributing to publications, 
conducting clinical trials and precepting and teaching 
students [18, 19, 21, 25, 26, 29, 31]. Ise et.al. found 
that Japanese pharmacists in their palliative care ward 
exercised a higher level of activity in educational and 
research roles than in clinical based work [29]. In 
contrast, Gilbar reported that active involvement in 
palliative care research was uncommon in Australia 
and Canada, with 16.7% of Australian phamacists 
and 1.7% of Canadian pharmacists involved [18]. 
Approximately 31% of Australian pharmacists and 
27.1% of Canadian pharmacists were involved in 
teaching palliative care to pharmacy, medical, or 
nursing students, 14.1% and 15.3% of Australian and 
Canadian pharmacists, respectively, actively participa-
ted in conferences or seminars, or contributed to the 
palliative care literature [18]. 
Differences across settings
It is apparent that in community-based or ho-
me-based care settings, emphasis is placed on roles 
related to adequate supply of stock for patients and 
in the development of a relationship with patients 
[3, 34]. Community pharmacists have been reported to 
develop a rapport with patients so that they can pro-
vide ongoing interpersonal support throughout pa-
tients stages of illness, and also to carers and family 
members in dealing with bereavement [3]. This role 
was less prominent in studies based in palliative ward 
or hospice settings. Furthermore, pharmacists in com-
munity settings reportedly followed-up patients after 
discharge from hospital to ensure they were managing 
their medications appropriately [3]. Pharmacists’ roles 
in hospice and palliative units were steered toward 
clinical roles such as medication chart reviews, adequ-
ate symptom management and collaboration with 
the interdisciplinary team. The USA-based studies in 
particular emphasise the importance of the pharmacist 
in communicating effectively with the team and pro-
viding advice and recommendations for appropriate 
changes to patients’ medication regimens, such as 
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— when to discontinue therapy, to change doses, to 
add medications [8, 19, 21, 25, 28]. 
Benefits
Several studies have described the value of phar-
macist involvement in the palliative care team. In the 
USA, pharmacists create individualised treatment 
plans for palliative patients, providing patient-centred 
care that takes into account their specific needs [16, 
22, 32]. The most commonly reported benefits of 
pharmacist interventions related to patient outcomes, 
including improved quality of life and level of com-
fort through adequate symptom control, appropriate 
medication regimens and medication adherence [3, 8, 
15, 18, 20–22, 27, 31]. Demler et al. highlighted that 
for palliative patients with pain and other distressing 
end-of-life symptoms, the effective and appropriate 
use of medications prevented negative experiences 
involving breakthrough pain as well as emergency 
department admissions, and as such helped to alle-
viate patient suffering [32]. Furthermore, a USA ar-
ticle highlighted that pharmacist’s recommendations 
minimised the possibility of adverse-effects, toxicities 
and use of unnecessary medications [16]. 
Several articles also highlighted that pharma-
cist’s involvement had positive associations for other 
members of the interdisciplinary team (i.e. doctors 
and nurses), including increased support and advice 
as well as preserving time for oncologists and other 
team members [8, 15, 18, 27]. Hussainy et.al. repor-
ted that in their Australian-based pilot intervention 
study involving the integration of a pharmacist into 
a community palliative care team, other clinical staff 
in the team reported an improvement in their medi-
cation-related knowledge and skills, with a decrease 
in related medication errors [20]. 
Also commonly identified were the economic be-
nefits of pharmacist roles. These included the use of 
more cost-effective medication regimens for patients 
and rationalising the use of medication to reduce 
unnecessary expenditure [16, 17, 22, 32]. The Swe-
dish article identified that following the inclusion of 
a pharmacist into the interdisciplinary palliative team, 
there was an observed improvement in the supply of 
medications and a 7% decrease in medication costs 
[30]. In retrospectively reviewing the medical records 
of patients admitted to a palliative unit in a commu-
nity hospital, Naidu et.al. reported that over a period 
of 1 year, pharmacist interventions related to the 
discontinuation of medications that did not support 
palliative care goals had a potential estimated direct 
cost savings of $100.000 (USD) [36]. 
Challenges/barriers
Among the barriers to the provision of pharma-
ceutical care to this patient population that have been 
identified in the literature, most related to the physical 
lack of pharmacists who possess the necessary skills for 
practising in palliative care, followed by the pharma-
cist’s lack of time for managing palliative patients needs 
[3, 18, 29, 31, 35]. In community pharmacies, where 
pharmacists look after patients in home-based and 
community centre settings, a significant issue related to 
the ordering of palliative specific medications with short 
shelf lives as well as pain medications. These concerns 
related to a perceived increased risk of theft as well 
as a fear of not being able to sell medications before 
their expiry dates [3]. In hospices or palliative wards, 
additional barriers include the: lack of a defined palliati-
ve pharmacist position or role, limited opportunities for 
interacting with other members of the palliative medical 
team, as well as little recognition for the contribution 
of the pharmacist in palliative care [18, 29]. 
Discussion
To our knowledge, this is the first review to compare 
the roles of palliative care pharmacists on an interna-
tional scale. Pharmacist practice in this setting is well 
publicised, however, we are unable to ascertain if these 
services are currently provided or offered to palliative 
patients worldwide due to the nature of the literature 
obtained, with several interventional studies and grey 
literature included in the review. However, it is apparent 
that, overall, those pharmacists who specialise in pallia-
tive care perform a diverse range of roles, ranging from 
quality assurance to being directly involved in patient 
care. As a result, the pharmacist can make significant 
contributions to palliative care, including appropria-
te symptom management, rational prescribing and 
psychological support, highlighting that they are well 
positioned in the holistic care of patients [37]. 
An important finding of this review highlights 
that pharmacist involvement in palliative care is not 
consistent worldwide. Whilst the literature collected 
is not representative of pharmaceutical care services 
on a global scale (due to the limited amount of lite-
rature from Asia, South America, Africa and Europe), 
it does provide an insight into the type of practice 
adopted in each country. Pharmacists in the UK, USA, 
Canada and Australia performed an advanced level of 
practice (as their reported roles fulfilled the criteria of 
the majority of the domains in the APPF). However, 
pharmacists in other countries, in particular Mexico 
and Poland, did not present such an extensive scope 
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of practice. Whilst the authors of the literature from 
these latter countries acknowledged that pharma-
cist involvement in palliative care settings was not 
highly developed, this draws attention to the gap in 
health equity between countries. The issue of health 
equity is of particular significance to palliative care, 
as the World Health Organisation (WHO) reports that 
a 2011 study conducted in 234 countries, territories 
and areas found that palliative care services were 
only well integrated in 20 countries, while 42% had 
no palliative care services at all and a further 32% 
had only isolated palliative care services [38]. Whilst 
these differences in practice between countries may 
be attributed to a wide variety of factors, including 
differences in health care systems, financing of pallia-
tive care, levels of palliative care services and practice 
culture, it is possible that as a result, patients in these 
countries are not provided with the highest attainable 
level of adequate pharmaceutical care, which may 
have varying levels of impact upon patient outcomes 
[39]. Equity is one of the fundamental principles of 
healthcare systems worldwide, and pharmacists, as 
well as medication experts must strive to equitably 
serve this patient population [40]. 
The WHO recommends several strategies to impro-
ve the provision of palliative care including: ensuring 
palliative care is delivered through inter-disciplinary 
teams; the implementation of a medications policy 
which ensures the availability of essential medications 
for managing symptoms, in particular opioid analge-
sics for the relief of pain and respiratory distress; as 
well as the development of policies for strengthening 
and expanding human resources, including training 
of existing health professionals [38]. Specifically for 
pharmacists, there are several palliative care specific 
educational opportunities that are able to develop 
pharmacist competencies [19]. These include the Scot-
tish Palliative Care Pharmacists Association learning 
pack, the ASHP Research and Education Foundation 
Pain and Palliative Care traineeship as well as several 
online pharmacist support groups [41–44]. The ASHP 
guidelines also provide a list of useful resources inc-
luding books, journals and websites that would be 
helpful in the professional development of the pal-
liative care pharmacist [19]. 
Whilst the value of the palliative care pharmacist is 
widely acknowledged in the literature, an important 
finding of this review highlights that it is apparent that 
pharmacists, as medication experts, are not utilised to 
their maximum potential in some palliative care settings 
worldwide. Therefore, there is a need to promote health 
equity and benchmarking among palliative practice 
settings on a global scale, so that there is consistency 
in the provision of good pharmaceutical care. 
Conclusions
Overall, whilst the majority of roles performed for 
this group of patients are similar to those performed 
in general clinical practice, there are several roles 
that were specifically emphasised as being important 
to this type of care, aimed at symptom control and 
achieving a comfortable quality of life, rather than cu-
rative treatments. The literature identifies that there 
are differences in the types of palliative pharmacist 
practice between countries, which may have varying 
levels of impact upon patient outcomes. As pharma-
cists can make significant contributions to palliative 
care, it is important to encourage the benchmarking 
of practice across different clinical settings and coun-
tries to promote a consistent and equitable practice. 
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